Quantcast

Latest Cytel Stories

2012-12-12 05:00:10

A PhUSE Single Day Event, “Indian Statistical Programming: GenNext” will take place in Hyderabad, India February 23rd, 2013 from 8:30am to 5pm.

2011-03-18 15:52:00

CAMBRIDGE, Mass., March 18, 2011 /PRNewswire/ -- Cytel Inc., premier provider of clinical trial design and implementation services and software, proudly announced today the addition of pharmaceutical and biotech industry veteran Jim Baker as Vice President, Clinical Research Services. Over his 28 year career, Baker has demonstrated biopharmaceutical development leadership at some of the world's top pharmaceutical, biotech and clinical research firms including Amgen®, Wyeth® and...

2009-06-22 18:11:00

Adaptive trials leader and CDRH regulators join to create Bayesian trial design and analysis software standard CAMBRIDGE, Mass., June 22 /PRNewswire/ -- Cytel Inc., a leading provider of biostatistical software and clinical trial design services, today announced the signing of a Cooperative Research And Development Agreement (CRADA) with the Center for Devices and Radiological Health (CDRH), a division of the United States Food and Drug Administration (FDA). The agreement acknowledges that...

2009-05-04 05:00:00

BOSTON, May 4 /PRNewswire-FirstCall/ -- Perceptive Informatics, the industry's leading eClinical solutions provider and a subsidiary of PAREXEL International Corporation (Nasdaq: PRXL), today announced the results of a survey conducted during its recent webinar entitled "Optimizing Adaptive Trial Designs: Using Simulation Methodologies to Overcome Challenges." The webinar, conducted by Perceptive Informatics with partner Cytel Inc., a provider of specialized statistical applications, was...

2009-02-13 13:59:00

Top Global Pharmaceutical Company Integrates Their Clinical Data System (CDS) and East(R) for Improved Clinical Data Handling and Trial Analysis CAMBRIDGE, Mass., Feb. 13 /PRNewswire/ -- Cytel Inc.


Word of the Day
shavie
  • A trick or prank.
The word 'shavie' is related to 'shave'.